Zhejiang Huakang Pharmaceutical Co., Ltd. Class ASSE: 605077

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Shareholding Reduction Plan by Shareholder Holding More Than 5% of the Shares

Sep 1, 2026 · Issued by Zhejiang Huakang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Shareholding Reduction Plan by Shareholder Holding More Than 5% of the Shares

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Huakang Pharmaceutical Co., Ltd. Class A

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Progress in Providing Guarantee Limit for Wholly-owned SubsidiaryAug 27
"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Completion of Repurchase and Cancellation of Certain Restricted Shares and Adjustment to the Conversion Price of "Huakang Convertible Bonds"Aug 25
"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Resolutions of the 4th Meeting of the 7th Board of DirectorsAug 21
"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on the Implementation of the Repurchase and Cancellation of Certain Restricted Shares under the Equity Incentive PlanAug 19

All Zhejiang Huakang Pharmaceutical Co., Ltd. Class A news releases